New Delhi: National health regulator Drug Controller General of India (DCGI) has asked drug maker GlaxoSmithKline (GSK) to withdraw promotional advertisement for cervical cancer vaccine, after it found the campaign to be violating certain norms.
According to sources, DCGI has sent a notice to the company asking them to withdraw the promotional campaign for ‘Cervarix´—the cervical cancer vaccine as it has violated the norms prescribed under the Drugs and Cosmetics Act 1940.
When contacted GSK spokesperson confirmed that the company has received a show cause notice from the DCGI.
“We have received a show cause notice from the DCGI regarding our disease awareness campaign on cervical cancer. We are in the process of responding to the same suitably,” a GSK spokesperson said.
The national health regulator has alleged that the campaign launched by the company for ‘Cervarix´ has violated the Drugs and Cosmetics Act 1940 norms, under which no one (neither company or any institute) can make any claim regarding prevention and cure of certain diseases.
According to the act, no drug may purport or claim to prevent or cure or may convey to the intending user thereof any idea that it may prevent or cure one or more of the diseases or ailments.
The act also states that before launching any campaign, prior permission of the government is needed.
According to the officials in the health ministry GSK has not taken any such permission.